152 related articles for article (PubMed ID: 35835507)
1. Subgroup-specific roles of primary cilia in medulloblastoma.
Marino S
Genes Dev; 2022 Jun; 36(11-12):650-651. PubMed ID: 35835507
[TBL] [Abstract][Full Text] [Related]
2. Primary cilia control translation and the cell cycle in medulloblastoma.
Youn YH; Hou S; Wu CC; Kawauchi D; Orr BA; Robinson GW; Finkelstein D; Taketo MM; Gilbertson RJ; Roussel MF; Han YG
Genes Dev; 2022 Jun; 36(11-12):737-751. PubMed ID: 35798383
[TBL] [Abstract][Full Text] [Related]
3. Primary Cilia in the Murine Cerebellum and in Mutant Models of Medulloblastoma.
Di Pietro C; Marazziti D; La Sala G; Abbaszadeh Z; Golini E; Matteoni R; Tocchini-Valentini GP
Cell Mol Neurobiol; 2017 Jan; 37(1):145-154. PubMed ID: 26935062
[TBL] [Abstract][Full Text] [Related]
4. Molecular subgroups of adult medulloblastoma: a long-term single-institution study.
Zhao F; Ohgaki H; Xu L; Giangaspero F; Li C; Li P; Yang Z; Wang B; Wang X; Wang Z; Ai L; Zhang J; Luo L; Liu P
Neuro Oncol; 2016 Jul; 18(7):982-90. PubMed ID: 27106407
[TBL] [Abstract][Full Text] [Related]
5. Role of MYC in Medulloblastoma.
Roussel MF; Robinson GW
Cold Spring Harb Perspect Med; 2013 Nov; 3(11):. PubMed ID: 24186490
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
7. From One to Many: Further Refinement of Medulloblastoma Subtypes Offers Promise for Personalized Therapy.
Bavle A; Parsons DW
Cancer Cell; 2017 Jun; 31(6):727-729. PubMed ID: 28609651
[TBL] [Abstract][Full Text] [Related]
8. Subgroup-specific alternative splicing in medulloblastoma.
Dubuc AM; Morrissy AS; Kloosterhof NK; Northcott PA; Yu EP; Shih D; Peacock J; Grajkowska W; van Meter T; Eberhart CG; Pfister S; Marra MA; Weiss WA; Scherer SW; Rutka JT; French PJ; Taylor MD
Acta Neuropathol; 2012 Apr; 123(4):485-499. PubMed ID: 22358458
[TBL] [Abstract][Full Text] [Related]
9. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
10. Dual and opposing roles of primary cilia in medulloblastoma development.
Han YG; Kim HJ; Dlugosz AA; Ellison DW; Gilbertson RJ; Alvarez-Buylla A
Nat Med; 2009 Sep; 15(9):1062-5. PubMed ID: 19701203
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways.
Deogharkar A; Singh SV; Bharambe HS; Paul R; Moiyadi A; Goel A; Shetty P; Sridhar E; Gupta T; Jalali R; Goel N; Gadewal N; Muthukumar S; Shirsat NV
Hum Mol Genet; 2021 Aug; 30(18):1721-1733. PubMed ID: 33949667
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma comprises four distinct molecular variants.
Northcott PA; Korshunov A; Witt H; Hielscher T; Eberhart CG; Mack S; Bouffet E; Clifford SC; Hawkins CE; French P; Rutka JT; Pfister S; Taylor MD
J Clin Oncol; 2011 Apr; 29(11):1408-14. PubMed ID: 20823417
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
14. Kif3a is necessary for initiation and maintenance of medulloblastoma.
Barakat MT; Humke EW; Scott MP
Carcinogenesis; 2013 Jun; 34(6):1382-92. PubMed ID: 23389290
[TBL] [Abstract][Full Text] [Related]
15. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
[TBL] [Abstract][Full Text] [Related]
16. Molecular correlates of cerebellar mutism syndrome in medulloblastoma.
Jabarkheel R; Amayiri N; Yecies D; Huang Y; Toescu S; Nobre L; Mabbott DJ; Sudhakar SV; Malik P; Laughlin S; Swaidan M; Al Hussaini M; Musharbash A; Chacko G; Mathew LG; Fisher PG; Hargrave D; Bartels U; Tabori U; Pfister SM; Aquilina K; Taylor MD; Grant GA; Bouffet E; Mankad K; Yeom KW; Ramaswamy V
Neuro Oncol; 2020 Feb; 22(2):290-297. PubMed ID: 31504816
[TBL] [Abstract][Full Text] [Related]
17. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Ramaswamy V; Remke M; Bouffet E; Faria CC; Perreault S; Cho YJ; Shih DJ; Luu B; Dubuc AM; Northcott PA; Schüller U; Gururangan S; McLendon R; Bigner D; Fouladi M; Ligon KL; Pomeroy SL; Dunn S; Triscott J; Jabado N; Fontebasso A; Jones DT; Kool M; Karajannis MA; Gardner SL; Zagzag D; Nunes S; Pimentel J; Mora J; Lipp E; Walter AW; Ryzhova M; Zheludkova O; Kumirova E; Alshami J; Croul SE; Rutka JT; Hawkins C; Tabori U; Codispoti KE; Packer RJ; Pfister SM; Korshunov A; Taylor MD
Lancet Oncol; 2013 Nov; 14(12):1200-7. PubMed ID: 24140199
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
19. Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage.
Reisinger D; Gojo J; Kasprian G; Haberler C; Peyrl A; Azizi AA; Mayr L; Chocholous M; Kool M; Czech T; Slavc I
Neurosurgery; 2020 Apr; 86(4):478-484. PubMed ID: 31065705
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma biology in the post-genomic era.
Archer TC; Pomeroy SL
Future Oncol; 2012 Dec; 8(12):1597-604. PubMed ID: 23231521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]